UV
Urmila Vijaykumar Mishra
About Urmila Vijaykumar Mishra
Data last updated:
Urmila Vijaykumar Mishra is a Director at Mediflowers India Private Limited (since 2019) and Director at Gentoss Pharmaceuticals India Private Limited (since 2021). The companies operate in Real Estate and Construction and Chemicals. The largest current company by reported revenue is Mediflowers India Private Limited at ₹12.8 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mediflowers India Private Limited U70109UP2019PTC123572 | Director | 19 Nov 2019 | 2019 | ₹12.8 Lakh (FY 2022) | Active |
| Gentoss Pharmaceuticals India Private Limited U24100UP2021PTC150798 | Director | 17 Aug 2021 | 2021 | Active |
Board colleagues of Urmila Vijaykumar Mishra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Kumar Mishra | 08616192 | Mediflowers India Private Limited , Gentoss Pharmaceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Urmila Vijaykumar Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Urmila Vijaykumar Mishra
Urmila Vijaykumar Mishra currently holds 2 directorships: Mediflowers India Private Limited (Director, since 19 Nov 2019, revenue ₹12.8 Lakh (FY 2022)); Gentoss Pharmaceuticals India Private Limited (Director, since 17 Aug 2021).
Urmila Vijaykumar Mishra was first appointed on 19 Nov 2019 as Director at Mediflowers India Private Limited. The most recent appointment on record is 17 Aug 2021 at Gentoss Pharmaceuticals India Private Limited.
The current boards of Urmila Vijaykumar Mishra's companies include Vijay Kumar Mishra (Mediflowers India Private Limited).